Media and News

See what’s new in the fight against AMR.

Live Twitter Feed

Tweets by AMResistance

10/19/2021

New drug for Acinetobacter infections shows promise in phase 3 trial

The antibiotic SUL-DUR stacked up well to colistin for 28-day mortality and outperformed it for clinical cure rate and kidney harm.

10/14/2021

Global TB deaths rise for first time in more than a decade

About 1.5 million people died from tuberculosis in 2020, up from 1.4 million in 2019, and reporting of cases has dropped substantially.

10/7/2021

Study highlights impact of antibiotic resistance on older Americans

In 2017, more than 11,000 US seniors died from common antibiotic-resistant infections.

10/19/2021

New drug for Acinetobacter infections shows promise in phase 3 trial

The antibiotic SUL-DUR stacked up well to colistin for 28-day mortality and outperformed it for clinical cure rate and kidney harm.

10/14/2021

Global TB deaths rise for first time in more than a decade

About 1.5 million people died from tuberculosis in 2020, up from 1.4 million in 2019, and reporting of cases has dropped substantially.

10/13/2021

CIDRAP Antimicrobial Stewardship Project Newsletter - Oct 14, 2021

10/7/2021

Study highlights impact of antibiotic resistance on older Americans

In 2017, more than 11,000 US seniors died from common antibiotic-resistant infections.

Share Your Story